MK
Mark Kaye
EVP & CFO

Mark Kaye insider trades: Elevance Health (ELV) stock sales

EVP & CFO, Elevance Health Last trade Oct 22, 2026 41 Form 4 filings
$4.7M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2019
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mark reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 22, 2026ELV↓ Sell$4.7M
Apr 24, 2025ELV↓ Sell$1.9M
Aug 7, 2023MCO↓ Sell$5.2M
May 19, 2023MCO↓ Sell$310K
Aug 15, 2022MCO↓ Sell$1.0M
Mar 2, 2022MCO↓ Sell$1.2M
Nov 18, 2021MCO↓ Sell$126K
Aug 16, 2021MCO↓ Sell$1.2M
Jul 1, 2021MCO↓ Sell$16K
May 20, 2021MCO↓ Sell$759K
Mar 2, 2021MCO↓ Sell$299K
Feb 16, 2021MCO↓ Sell$218K
Nov 11, 2020MCO↓ Sell$495K
Apr 9, 2020MCO↓ Sell$845K
Dec 5, 2019MCO↓ Sell$829K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ELV insiders

Open-market trades in the last 12 months

About Mark Kaye's insider trades

Mark Kaye is EVP & CFO at Elevance Health (ELV). Since Dec 5, 2019, Mark has reported no open-market purchases and 15 sales worth $19.1M on SEC Form 4. In the last 12 months: 1 sale ($4.7M).

Their filings also include grants and awards (19 filings), shares withheld for taxes (14 filings), option exercises (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.